UG Healthcare (Catalist:8K7) - Stock Price, News & Analysis

8K7 Stock Overview

An investment holding company, manufactures and sells disposable gloves. More details

8K7 fundamental analysis
Snowflake Score
Valuation	2/6
Future Growth	0/6
Past Performance	0/6
Financial Health	4/6
Dividends	0/6

Risk Analysis

Earnings have declined by 23.8% per year over past 5 years

Does not have a meaningful market cap (SGD75M)

UG Healthcare Corporation Limited Competitors

Medtecs International

Catalist:546

S$75.7m

Riverstone Holdings

SGX:AP4

S$1.6b

Vicplas International

SGX:569

S$50.6m

Biolidics

Catalist:8YY

S$23.7m

Price History & Performance

Summary of all time highs, changes and price drops for UG Healthcare
Historical stock prices
Current Share Price	S$0.12
52 Week High	S$0.23
52 Week Low	S$0.091
Beta	0.93
11 Month Change	-1.63%
3 Month Change	-2.42%
1 Year Change	21.00%
33 Year Change	-57.54%
5 Year Change	159.29%
Change since IPO	45.20%

Recent updates

Shareholder Returns

	8K7	SG Medical Equipment	SG Market
7D	4.3%	0.5%	2.3%
1Y	21.0%	-0.6%	16.6%

Return vs Industry: 8K7 exceeded the SG Medical Equipment industry which returned -0.6% over the past year.

Return vs Market: 8K7 exceeded the SG Market which returned 16.6% over the past year.

Price Volatility

Is 8K7's price volatile compared to industry and market?
8K7 volatility
8K7 Average Weekly Movement	4.4%
Medical Equipment Industry Average Movement	7.0%
Market Average Movement	4.5%
10% most volatile stocks in SG Market	14.2%
10% least volatile stocks in SG Market	2.1%

Stable Share Price: 8K7 has not had significant price volatility in the past 3 months compared to the SG market.

Volatility Over Time: 8K7's weekly volatility has decreased from 11% to 4% over the past year.

About the Company

Founded	Employees	CEO	Website
1989	898	Keck Keong Lee	www.ughealthcarecorporation.com

UG Healthcare Corporation Limited, an investment holding company, manufactures and sells disposable gloves. The company operates through Latex Examination Gloves, Nitrile Examination Gloves, and Other Ancillary Products segments. It distributes ancillary products, including surgical gloves, vinyl and cleanroom disposable gloves, face masks, and other medical disposables.

UG Healthcare Corporation Limited Fundamentals Summary

How do UG Healthcare's earnings and revenue compare to its market cap?
8K7 fundamental statistics
Market cap	S$75.48m
Earnings (TTM)	-S$6.06m
Revenue (TTM)	S$115.21m

0.7x

P/S Ratio

-12.5x

P/E Ratio

Is 8K7 overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
8K7 income statement (TTM)
Revenue	S$115.21m
Cost of Revenue	S$89.34m
Gross Profit	S$25.87m
Other Expenses	S$31.92m
Earnings	-S$6.06m

Last Reported Earnings

Jun 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)	-0.0097
Gross Margin	22.45%
Net Profit Margin	-5.26%
Debt/Equity Ratio	26.6%

How did 8K7 perform over the long term?

See historical performance and comparison

8K7 Stock Overview

Risk Analysis

UG Healthcare Corporation Limited Competitors

Catalist:546

S$75.7m

SGX:AP4

S$1.6b

SGX:569

S$50.6m

Catalist:8YY

S$23.7m

Price History & Performance

Recent News & Updates

Ug Healthcare Corporation Limited Announces Appointment of Law Cheong Yan as Independent Non-Executive Director Chairman of Nominating Committee Member of Audit Committee Member of Remuneration Committee, Effective from December 2,2024

Full year 2024 earnings released: S$0.01 loss per share (vs S$0.033 loss in FY 2023)

UG Healthcare Corporation Limited, Annual General Meeting, Oct 29, 2024

Ug Healthcare Corporation Limited Announces Retirement of Mr. Wong See Keong as Executive Director, Effective 29 October 2024

Full year 2024 earnings released: S$0.01 loss per share (vs S$0.033 loss in FY 2023)

UG Healthcare Corporation Limited to Report Fiscal Year 2024 Results on Aug 29, 2024

Recent updates

Ug Healthcare Corporation Limited Announces Appointment of Law Cheong Yan as Independent Non-Executive Director Chairman of Nominating Committee Member of Audit Committee Member of Remuneration Committee, Effective from December 2,2024

Full year 2024 earnings released: S$0.01 loss per share (vs S$0.033 loss in FY 2023)

UG Healthcare Corporation Limited, Annual General Meeting, Oct 29, 2024

Ug Healthcare Corporation Limited Announces Retirement of Mr. Wong See Keong as Executive Director, Effective 29 October 2024

Full year 2024 earnings released: S$0.01 loss per share (vs S$0.033 loss in FY 2023)

UG Healthcare Corporation Limited to Report Fiscal Year 2024 Results on Aug 29, 2024

UG Healthcare Corporation Limited (Catalist:8K7) completed the acquisition of 50% stake in UG NITREX, S. L. from Afaprot, S. L. and Martínez for €0.5 million.

First half 2024 earnings released: S$0.008 loss per share (vs S$0.008 loss in 1H 2023)

New major risk - Revenue and earnings growth

UG Healthcare Corporation Limited to Report First Half, 2024 Results on Feb 13, 2024

UG Healthcare Corporation Limited Announces Appointment of Ng Lee Eng as Independent Non-Executive Director Chairman of Nominating Committee Member of Audit Committee Member of Remuneration Committee

New minor risk - Share price stability

UG Healthcare Corporation Limited Announces Cessation Vincent Leow as Independent Non-Executive Director Chairman of Nominating Committee Member of Audit Committee Member of Remuneration Committee

Full year 2023 earnings released: S$0.033 loss per share (vs S$0.059 profit in FY 2022)

UG Healthcare Corporation Limited, Annual General Meeting, Oct 30, 2023

Full year 2023 earnings released: S$0.033 loss per share (vs S$0.059 profit in FY 2022)

New minor risk - Financial data availability

First half 2023 earnings released: S$0.008 loss per share (vs S$0.034 profit in 1H 2022)

UG Healthcare Corporation Limited to Report First Half, 2023 Results on Feb 14, 2023

Less than half of directors are independent

UG Healthcare Corporation Limited Approves Special Cash Dividend for the Financial Year Ended 30 June 2022, Payable on 16 December 2022

UG Healthcare Corporation Limited (Catalist:8K7) entered into a share sale agreement to acquire Indigo Teguh Sdn Bhd from Lee Keck Keong for MYR 100.

Full year 2022 earnings: EPS and revenues exceed analyst expectations

UG Healthcare Corporation Limited, Annual General Meeting, Oct 28, 2022

Consensus revenue estimates fall by 12%

Full year 2022 earnings: EPS and revenues exceed analyst expectations

UG Healthcare Corporation Limited Recommends Tax Exempt Special Dividend for Fiscal Year 2022

Less than half of directors are independent

Now 20% undervalued after recent price drop

Second quarter 2022 earnings: EPS and revenues exceed analyst expectations

UG Healthcare Corporation Limited to Report First Half, 2022 Results on Feb 11, 2022

UG Healthcare Corporation Limited to Report First Half, 2022 Results on Feb 11, 2022

Price target decreased to S$0.44

Full year 2021 earnings released: EPS S$0.19 (vs S$0.023 in FY 2020)

Price target decreased to S$0.55

Less than half of directors are independent

UG Healthcare Corporation Limited Provides Update on Covid-19 Situation in the Group's Manufacturing Division in Malaysia

Company Secretary Kar Yeoh has left the company

Third quarter 2021 earnings released: EPS S$0.056 (vs S$0.011 in 3Q 2020)

Price target decreased to S$0.99

Second quarter 2021 earnings released

UG Healthcare Corporation Limited to Report First Half, 2021 Results on Feb 04, 2021

New 90-day low: S$0.36

New 90-day low: S$0.23

New 90-day low: S$0.60

New 90-day low: S$0.64

First quarter 2021 earnings released: EPS S$0.039

Analysts update estimates

Annual earnings released: Revenue and earnings beat expectations

Full year earnings released - EPS S$0.023

Analysts increase revenue estimates to S$240.3m

UG Healthcare Corporation Limited has completed a Follow-on Equity Offering in the amount of SGD 19.0875 million.

Analysts increase revenue estimates to S$180.9m

Full year earnings released - EPS S$0.068

New 90-day high - S$2.91

Shareholder Returns

Price Volatility

About the Company

UG Healthcare Corporation Limited Fundamentals Summary

0.7x